Unraveling the genomic determinants of response to CDK4/6 inhibitors
Oncotarget
.
2018 Dec 7;9(96):36822-36823.
doi: 10.18632/oncotarget.26109.
Authors
Lacey M Litchfield
1
,
Vue W Webster
1
,
Sean G Buchanan
1
Affiliation
1
Sean G. Buchanan: Eli Lilly and Company, Indianapolis, IN, USA.
PMID:
30627319
PMCID:
PMC6305152
DOI:
10.18632/oncotarget.26109
No abstract available
Keywords:
CCND1; CCND2; CCND3; CDK2; CDK4/6.
Publication types
Editorial